Basics Design Therapeutics, Inc. IPO Date: March 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $558.24M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.60% Avg Daily Range (30 D): $0.30 | 3.17% Avg Daily Range (90 D): $0.30 | 4.10% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .36M Avg Daily Volume (90 D): .28M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 89 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 289 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $1.79M Avg Inst. Trade (90 D): $2.84M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.39M Avg Closing Trade (30 D): $2.06M Avg Closing Trade (90 D): $2.5M Avg Closing Volume: 191.81K     News Nov 26, 2025 @ 1:00 PM Design Therapeutics to Participate in Upcoming Inv... Source: Renee Leck May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc. Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc. Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.19 $-.3 $-.34 Diluted EPS $-1.19 $-.3 $-.34 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -67.45M $ -17M $ -19.08M Operating Income / Loss $ -77.99M $ -19.31M $ -21.57M Cost of Revenue $ $ $ Net Cash Flow $ -15.24M $ -4.62M $ 6.04M PE Ratio